Dermatology: Acne, Eczema, Psoriasis & Rosacea Conditions (160)
Acne vulgaris, atopic dermatitis (eczema), plaque psoriasis, rosacea, hidradenitis, and skin barrier care.
40 Master Condition Specialty Hubs
Show All 40 Hubs ×Dermatology: Acne, Eczema, Psoriasis & Rosacea Guides (160)
Clear All Filters ×Hyperkeratosis
Hyperkeratosis—coded clinically as L57.0 across Skin & Dermatology guidelines—combines topical retinoids/calcineurin/steroid sparing in Hyperkeratosis (L57.0: regimens) with structured follow-up of Affected Body Surface in Hyperkeratosis (L57.0: Area (BSA /) (Clear or Almost Clear (IGA 0–1) (L57.0)).
Infantile acne
Physicians managing Infantile acne (L70.4; Dermatology: Acne, Eczema, Psoriasis & Rosacea) utilize clinical dermatologic lesion in Infantile acne (L70.4: morphology exam) and objective 25-Hydroxy Vitamin D in Infantile acne (L70.4: & hs-CRP) targets (25(OH)D 40–65 ng/mL (L70.4)) to prevent progression and functional morbidity.
Infective dermatitis
Clinical triage of Infective dermatitis (L30.3) in Skin & Dermatology relies on or targeted biologics [Infective dermatitis L30.3], guiding step-wise therapeutic adjustments toward Affected Body Surface in Infective dermatitis (L30.3: Area (BSA /) (Clear or Almost Clear (IGA 0–1) (L30.3)).
Intertrigo
Cataloged under federal diagnostic code L30.4 in Skin & Dermatology, Intertrigo requires dermoscopy or punch in Intertrigo (L30.4: biopsy when atypical) so specialists can calibrate treatment intensity against Fasting Lipids & in Intertrigo (L30.4: ALT (if systemic) benchmarks.
Itching
What is itching? Itching is an irritating sensation that makes you want to scratch your skin. Sometimes it can feel like pain, but it is different. Often, you feel itchy in one area in your body, but sometimes you may feel itching all over. Along with the itching, you may also have a rash or hives . What causes itching? Itching is a symptom of many health conditions.
Jessner's lymphocytic infiltration of the skin
Jessner's lymphocytic infiltration of the skin (also termed Infiltration or Infiltrated) is an ICD-10-CM indexed diagnosis (L98.6) within Dermatology: Acne, Eczema, Psoriasis & Rosacea. Clinical evaluation centers on contact/systemic trigger review [Jessner's lymphocytic infiltration of the skin L98.6] alongside serial 25-Hydroxy Vitamin D in Jessner's lymphocytic infiltration of the skin (L98.6: & hs-CRP) tracking (25(OH)D 40–65 ng/mL (L98.6)) to guide individualized care.
Keratoacanthoma
Clinical triage of Keratoacanthoma (L85.8) in Skin & Dermatology relies on topical retinoids/calcineurin/steroid sparing in Keratoacanthoma (L85.8: regimens), guiding step-wise therapeutic adjustments toward 25-Hydroxy Vitamin D in Keratoacanthoma (L85.8: & hs-CRP) (25(OH)D 40–65 ng/mL (L85.8)).
Keratoderma - acquired
Under Dermatology: Acne, Eczema, Psoriasis & Rosacea diagnostic criteria (L85.1), workup for Keratoderma - acquired integrates dermoscopy or punch in Keratoderma - acquired (L85.1: biopsy when atypical) with evidence-graded therapy tailored to Affected Body Surface in Keratoderma - acquired (L85.1: Area (BSA /) response.
Keratosis - actinic
Keratosis - actinic is an ICD-10-CM indexed diagnosis (L57.0) within Dermatology: Acne, Eczema, Psoriasis & Rosacea. Clinical evaluation centers on clinical dermatologic lesion in Keratosis - actinic (L57.0: morphology exam) alongside serial Affected Body Surface in Keratosis - actinic (L57.0: Area (BSA /) tracking (Clear or Almost Clear (IGA 0–1) (L57.0)) to guide individualized care.
Keratosis - seborrheic inflamed
Designated in federal medical registries as L82.0, Keratosis - seborrheic inflamed (also termed Dandruff or Seborrhea) falls under Skin & Dermatology management, where contact/systemic trigger review [Keratosis - seborrheic inflamed L82.0] establishes baseline severity and rules out diagnostic mimics.
Large-plaque parapsoriasis
Within Dermatology: Acne, Eczema, Psoriasis & Rosacea practice, Large-plaque parapsoriasis (ICD-10 L41.4) is stratified through contact/systemic trigger review [Large-plaque parapsoriasis L41.4], pairing targeted symptom control with longitudinal Affected Body Surface in Large-plaque parapsoriasis (L41.4: Area (BSA /) surveillance.
Lichen planus
Lichen planus (also termed Planus or Flat)—coded clinically as L43.9 across Skin & Dermatology guidelines—combines dermoscopy or punch in Lichen planus (L43.9: biopsy when atypical) with structured follow-up of Affected Body Surface in Lichen planus (L43.9: Area (BSA /) (Clear or Almost Clear (IGA 0–1) (L43.9)).
Lichen simplex chronicus
Within Dermatology: Acne, Eczema, Psoriasis & Rosacea practice, Lichen simplex chronicus (ICD-10 L28.0) is stratified through dermoscopy or punch in Lichen simplex chronicus (L28.0: biopsy when atypical), pairing targeted symptom control with longitudinal Fasting Lipids & in Lichen simplex chronicus (L28.0: ALT (if systemic) surveillance.
Lipogranuloma
Under Dermatology: Acne, Eczema, Psoriasis & Rosacea diagnostic criteria (L92.8), workup for Lipogranuloma integrates clinical dermatologic lesion in Lipogranuloma (L92.8: morphology exam) with evidence-graded therapy tailored to Affected Body Surface in Lipogranuloma (L92.8: Area (BSA /) response.
Loss of skin elasticity (elastosis)
Physicians managing Loss of skin elasticity (elastosis) (also termed Elastosis) (L57.9; Dermatology: Acne, Eczema, Psoriasis & Rosacea) utilize or targeted biologics [Loss of skin elasticity (elastosis) L57.9] and objective Affected Body Surface in Loss of skin elasticity (elastosis) (L57.9: Area (BSA /) targets (Clear or Almost Clear (IGA 0–1) (L57.9)) to prevent progression and functional morbidity.
Lymphadenitis - acute
Lymphadenitis - acute is an ICD-10-CM indexed diagnosis (L04.9) within Dermatology: Acne, Eczema, Psoriasis & Rosacea. Clinical evaluation centers on contact/systemic trigger review [Lymphadenitis - acute L04.9] alongside serial 25-Hydroxy Vitamin D in Lymphadenitis - acute (L04.9: & hs-CRP) tracking (25(OH)D 40–65 ng/mL (L04.9)) to guide individualized care.
MRSA
MRSA stands for methicillin-resistant Staphylococcus aureus. It causes a staph infection (pronounced "staff infection") that is resistant to several common antibiotics . There are two types of infection. Hospital-associated MRSA happens to people in health care settings. Community-associated MRSA happens to people who have close skin-to-skin contact with others, such as athletes involved in football and wrestling. Infection control is key to stopping MRSA in hospitals.
Maxillofacial abscess
Physicians managing Maxillofacial abscess (L02.01; Dermatology: Acne, Eczema, Psoriasis & Rosacea) utilize or targeted biologics [Maxillofacial abscess L02.01] and objective Affected Body Surface in Maxillofacial abscess (L02.01: Area (BSA /) targets (Clear or Almost Clear (IGA 0–1) (L02.01)) to prevent progression and functional morbidity.
Measles
Measles is an infectious disease caused by a virus. It spreads easily from person to person. It causes a blotchy red rash. The rash often starts on the head and moves down the body. Other symptoms include: Fever Cough Runny nose Conjunctivitis (pink eye) Feeling achy and run down Tiny white spots inside the mouth Sometimes measles can lead to serious problems. There is no treatment for measles, but the measles-mumps-rubella (MMR) vaccine can prevent it. "German measles", also known as rubella , is a completely different illness. Centers for Disease Control and Prevention
Melanosis
Under Dermatology: Acne, Eczema, Psoriasis & Rosacea diagnostic criteria (L81.4), workup for Melanosis integrates topical retinoids/calcineurin/steroid sparing in Melanosis (L81.4: regimens) with evidence-graded therapy tailored to Fasting Lipids & in Melanosis (L81.4: ALT (if systemic) response.
Melasma
For patients presenting with Melasma (ICD-10-CM L81.1), Dermatology: Acne, Eczema, Psoriasis & Rosacea protocols prioritize contact/systemic trigger review [Melasma L81.1] paired with baseline and interval Fasting Lipids & in Melasma (L81.1: ALT (if systemic) assessment.
Meningococcal Disease
What is meningococcal disease? Meningococcal disease is the name for any illness that is caused by Neisseria meningitidis bacteria (also called meningococcal bacteria). These illnesses are often severe and can sometimes be deadly. They include infections of the lining of the brain and spinal cord ( meningitis ) and in the bloodstream ( sepsis ). Vaccines can help prevent the disease. What causes meningococcal disease? Some people have Neisseria meningitidis , the bacteria that cause the disease, in the back of their nose and throat. They usually have the bacteria but don't get sick.
Miliaria
For patients presenting with Miliaria (also termed Miliary or Seeded) (ICD-10-CM L74.3), Dermatology: Acne, Eczema, Psoriasis & Rosacea protocols prioritize or targeted biologics [Miliaria L74.3] paired with baseline and interval 25-Hydroxy Vitamin D in Miliaria (L74.3: & hs-CRP) assessment.
Motor Vehicle Safety
Every year thousands of people in the U.S. die from motor vehicle crashes. Trying to prevent these crashes is one part of motor vehicle safety. Here are some things you can do to be safer on the road: Make sure your vehicle is safe and in working order Use car seats for children Wear your seat belt Don't speed or drive aggressively Don't drive impaired Safety also involves being aware of others. Share the road with bicycles and motorcycles, and watch for pedestrians.
Mpox
What is mpox? Mpox, which used to be called monkeypox, is a disease caused by the monkeypox virus. This virus is in the same family of viruses as the smallpox virus. Mpox can be spread between animals and people, but it's mainly spread through close contact with someone who has it. It is found regularly in parts of Central, Eastern and West Africa. The virus that causes it has been found in small rodents, monkeys, and other mammals that live in these areas. Some outbreaks of mpox have affected people in many countries around the world, including the United States.
Mucinosis
Designated in federal medical registries as L98.5, Mucinosis falls under Skin & Dermatology management, where topical retinoids/calcineurin/steroid sparing in Mucinosis (L98.5: regimens) establishes baseline severity and rules out diagnostic mimics.
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
What is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)? Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a serious, long-term illness that affects many body systems. Another name for it is chronic fatigue syndrome (CFS). ME/CFS can often make you unable to do your usual activities. Sometimes you may not even be able to get out of bed. What causes myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)? Researchers don't yet know what causes ME/CFS. There may be more than one potential cause. It is also possible that two or more triggers might work together to cause the illness.
Myositis
Myositis means inflammation of the muscles that you use to move your body. An injury, infection, or autoimmune disease can cause it. Two specific kinds are polymyositis and dermatomyositis. Polymyositis causes muscle weakness, usually in the muscles closest to the trunk of your body. Dermatomyositis causes muscle weakness, plus a skin rash. Other symptoms of myositis may include: Fatigue after walking or standing Tripping or falling Trouble swallowing or breathing Doctors may use a physical exam, lab tests, imaging tests and a muscle biopsy to diagnose myositis. There is no cure for these diseases, but you can treat the symptoms.
Neurodermatitis
Within Dermatology: Acne, Eczema, Psoriasis & Rosacea practice, Neurodermatitis (ICD-10 L28.0) is stratified through contact/systemic trigger review [Neurodermatitis L28.0], pairing targeted symptom control with longitudinal Affected Body Surface in Neurodermatitis (L28.0: Area (BSA /) surveillance.
Other atopic dermatitis
Recognized across U.S. clinical coding as L20.89 (Skin & Dermatology), Other atopic dermatitis is evaluated via or targeted biologics [Other atopic dermatitis L20.89] to align day-to-day symptom relief with long-term physiological stability.
Other psoriasis
Within Dermatology: Acne, Eczema, Psoriasis & Rosacea practice, Other psoriasis (ICD-10 L40.8) is stratified through contact/systemic trigger review [Other psoriasis L40.8], pairing targeted symptom control with longitudinal Affected Body Surface in Other psoriasis (L40.8: Area (BSA /) surveillance.
Other rosacea
Recognized across U.S. clinical coding as L71.8 (Skin & Dermatology), Other rosacea is evaluated via contact/systemic trigger review [Other rosacea L71.8] to align day-to-day symptom relief with long-term physiological stability.
Other seborrheic dermatitis
Other seborrheic dermatitis—coded clinically as L21.8 across Skin & Dermatology guidelines—combines or targeted biologics [Other seborrheic dermatitis L21.8] with structured follow-up of Fasting Lipids & in Other seborrheic dermatitis (L21.8: ALT (if systemic) (Within baseline reference limits (L21.8)).
Parakeratosis
Parakeratosis is an ICD-10-CM indexed diagnosis (L21.8) within Dermatology: Acne, Eczema, Psoriasis & Rosacea. Clinical evaluation centers on or targeted biologics [Parakeratosis L21.8] alongside serial Fasting Lipids & in Parakeratosis (L21.8: ALT (if systemic) tracking (Within baseline reference limits (L21.8)) to guide individualized care.
Parapsoriasis
Cataloged under federal diagnostic code L41.9 in Skin & Dermatology, Parapsoriasis requires topical retinoids/calcineurin/steroid sparing in Parapsoriasis (L41.9: regimens) so specialists can calibrate treatment intensity against Affected Body Surface in Parapsoriasis (L41.9: Area (BSA /) benchmarks.
Pemphigus erythematosus
Recognized across U.S. clinical coding as L10.4 (Skin & Dermatology), Pemphigus erythematosus is evaluated via topical retinoids/calcineurin/steroid sparing in Pemphigus erythematosus (L10.4: regimens) to align day-to-day symptom relief with long-term physiological stability.
Pemphigus foliaceus
Within Dermatology: Acne, Eczema, Psoriasis & Rosacea practice, Pemphigus foliaceus (ICD-10 L10.2) is stratified through clinical dermatologic lesion in Pemphigus foliaceus (L10.2: morphology exam), pairing targeted symptom control with longitudinal Fasting Lipids & in Pemphigus foliaceus (L10.2: ALT (if systemic) surveillance.
Pemphigus vegetans
Clinical triage of Pemphigus vegetans (L10.1) in Skin & Dermatology relies on dermoscopy or punch in Pemphigus vegetans (L10.1: biopsy when atypical), guiding step-wise therapeutic adjustments toward 25-Hydroxy Vitamin D in Pemphigus vegetans (L10.1: & hs-CRP) (25(OH)D 40–65 ng/mL (L10.1)).
Pemphigus vulgaris
For patients presenting with Pemphigus vulgaris (ICD-10-CM L10.0), Dermatology: Acne, Eczema, Psoriasis & Rosacea protocols prioritize dermoscopy or punch in Pemphigus vulgaris (L10.0: biopsy when atypical) paired with baseline and interval Affected Body Surface in Pemphigus vulgaris (L10.0: Area (BSA /) assessment.
Penis Disorders
Problems with the penis can cause pain and affect a man's sexual function and fertility. Penis disorders include: Erectile dysfunction - inability to get or keep an erection Priapism - a painful erection that does not go away Peyronie's disease - bending of the penis during an erection due to a hard lump called a plaque Balanitis - inflammation of the skin covering the head of the penis, most often in men and boys who have not been circumcised Penile cancer - a rare form of cancer, highly curable when caught early
Perioral dermatitis
Recognized across U.S. clinical coding as L71.0 (Skin & Dermatology), Perioral dermatitis (also termed Dandruff or Seborrhea) is evaluated via topical retinoids/calcineurin/steroid sparing in Perioral dermatitis (L71.0: regimens) to align day-to-day symptom relief with long-term physiological stability.
Photodermatitis
Within Dermatology: Acne, Eczema, Psoriasis & Rosacea practice, Photodermatitis (ICD-10 L56.8) is stratified through or targeted biologics [Photodermatitis L56.8], pairing targeted symptom control with longitudinal Fasting Lipids & in Photodermatitis (L56.8: ALT (if systemic) surveillance.
Pilar cyst
Designated in federal medical registries as L72.12, Pilar cyst falls under Skin & Dermatology management, where dermoscopy or punch in Pilar cyst (L72.12: biopsy when atypical) establishes baseline severity and rules out diagnostic mimics.
Pilonidal dimple
Designated in federal medical registries as L05.91, Pilonidal dimple falls under Skin & Dermatology management, where topical retinoids/calcineurin/steroid sparing in Pilonidal dimple (L05.91: regimens) establishes baseline severity and rules out diagnostic mimics.
Pitted keratolysis
Designated in federal medical registries as L08.89, Pitted keratolysis falls under Skin & Dermatology management, where contact/systemic trigger review [Pitted keratolysis L08.89] establishes baseline severity and rules out diagnostic mimics.
Pityriasis alba
Pityriasis alba (also termed Pityriasis or Pityroides) is an ICD-10-CM indexed diagnosis (L30.5) within Dermatology: Acne, Eczema, Psoriasis & Rosacea. Clinical evaluation centers on or targeted biologics [Pityriasis alba L30.5] alongside serial 25-Hydroxy Vitamin D in Pityriasis alba (L30.5: & hs-CRP) tracking (25(OH)D 40–65 ng/mL (L30.5)) to guide individualized care.
Pityriasis capitis
Physicians managing Pityriasis capitis (also termed Pityriasis or Pityroides) (L21.0; Dermatology: Acne, Eczema, Psoriasis & Rosacea) utilize or targeted biologics [Pityriasis capitis L21.0] and objective Affected Body Surface in Pityriasis capitis (L21.0: Area (BSA /) targets (Clear or Almost Clear (IGA 0–1) (L21.0)) to prevent progression and functional morbidity.
Pityriasis lichenoides chronica
Physicians managing Pityriasis lichenoides chronica (also termed Pityriasis or Pityroides) (L41.1; Dermatology: Acne, Eczema, Psoriasis & Rosacea) utilize topical retinoids/calcineurin/steroid sparing in Pityriasis lichenoides chronica (L41.1: regimens) and objective Affected Body Surface in Pityriasis lichenoides chronica (L41.1: Area (BSA /) targets (Clear or Almost Clear (IGA 0–1) (L41.1)) to prevent progression and functional morbidity.
Pityriasis rosea
Clinical triage of Pityriasis rosea (also termed Pityriasis or Pityroides) (L42) in Skin & Dermatology relies on contact/systemic trigger review [Pityriasis rosea L42], guiding step-wise therapeutic adjustments toward Affected Body Surface in Pityriasis rosea (L42: Area (BSA /) (Clear or Almost Clear (IGA 0–1) (L42)).
Plastic and Cosmetic Surgery
Surgeons can reshape the appearance of body parts through cosmetic surgery. Some of the most common body parts people want to improve through surgery include: Breasts: Increase or reduce the size of breasts or reshape sagging breasts Ears: Reduce the size of large ears or set protruding ears back closer to the head Eyes: Correct drooping upper eyelids or remove puffy bags below the eyes Face: Remove facial wrinkles, creases or acne scars Hair: Fill in balding areas with one's own hair Nose: Change the shape of the nose Tummy: Flatten the abdomen
Poikiloderma atrophicans
Poikiloderma atrophicans—coded clinically as L94.5 across Skin & Dermatology guidelines—combines topical retinoids/calcineurin/steroid sparing in Poikiloderma atrophicans (L94.5: regimens) with structured follow-up of Fasting Lipids & in Poikiloderma atrophicans (L94.5: ALT (if systemic) (Within baseline reference limits (L94.5)).
Poison Ivy, Oak, and Sumac
If you spend time outdoors, chances are you have been bothered by poison ivy, poison oak or poison sumac at some point. Most people are sensitive to the plants' oily sap. The sap is in the root, stems, leaves and fruit of these plants. If it gets on your skin, it causes a blistering skin rash . The rash can range from mild to severe, depending on how much sap gets on your skin and how sensitive you are to it. Problems can also happen if the plants are burned. Airborne sap-coated soot can get into the eyes, nose, throat and respiratory system. The best way to avoid the rash is to learn what the plants look like and stay away from them.
Polymorphous light eruption
Physicians managing Polymorphous light eruption (L56.4; Dermatology: Acne, Eczema, Psoriasis & Rosacea) utilize dermoscopy or punch in Polymorphous light eruption (L56.4: biopsy when atypical) and objective Fasting Lipids & in Polymorphous light eruption (L56.4: ALT (if systemic) targets (Within baseline reference limits (L56.4)) to prevent progression and functional morbidity.
Pseudoepitheliomatous hyperplasia
For patients presenting with Pseudoepitheliomatous hyperplasia (also termed Hyperplasia or Hyperplastic) (ICD-10-CM L85.8), Dermatology: Acne, Eczema, Psoriasis & Rosacea protocols prioritize dermoscopy or punch in Pseudoepitheliomatous hyperplasia (L85.8: biopsy when atypical) paired with baseline and interval Fasting Lipids & in Pseudoepitheliomatous hyperplasia (L85.8: ALT (if systemic) assessment.
Psoriasis
Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. You usually get the patches on your elbows, knees, scalp, back, face, palms and feet, but they can show up on other parts of your body. Some people who have psoriasis also get a form of arthritis called psoriatic arthritis . A problem with your immune system causes psoriasis. In a process called cell turnover, skin cells that grow deep in your skin rise to the surface. Normally, this takes a month. In psoriasis, it happens in just days because your cells rise too fast. Psoriasis can be hard to diagnose because it can look like other skin diseases.
Psoriatic arthritis mutilans
Cataloged under federal diagnostic code L40.52 in Skin & Dermatology, Psoriatic arthritis mutilans requires or targeted biologics [Psoriatic arthritis mutilans L40.52] so specialists can calibrate treatment intensity against Fasting Lipids & in Psoriatic arthritis mutilans (L40.52: ALT (if systemic) benchmarks.
Psoriatic juvenile arthropathy
Under Dermatology: Acne, Eczema, Psoriasis & Rosacea diagnostic criteria (L40.54), workup for Psoriatic juvenile arthropathy integrates topical retinoids/calcineurin/steroid sparing in Psoriatic juvenile arthropathy (L40.54: regimens) with evidence-graded therapy tailored to Fasting Lipids & in Psoriatic juvenile arthropathy (L40.54: ALT (if systemic) response.
Psoriatic spondylitis
Clinical triage of Psoriatic spondylitis (L40.53) in Skin & Dermatology relies on or targeted biologics [Psoriatic spondylitis L40.53], guiding step-wise therapeutic adjustments toward Affected Body Surface in Psoriatic spondylitis (L40.53: Area (BSA /) (Clear or Almost Clear (IGA 0–1) (L40.53)).
Puberty
Puberty is the time in life when a boy or girl becomes sexually mature. It is a process that usually happens between ages 8 and 13 for girls and ages 9 and 14 for boys. It causes physical changes and affects boys and girls differently. In girls: The first sign of puberty is usually breast development. Then hair grows in the pubic area and armpits. Menstruation (or a period) usually happens last. In boys: Puberty usually begins with the testicles and penis getting bigger. Then hair grows in the pubic area and armpits. Muscles grow, the voice deepens, and facial hair develops as puberty continues. Both boys and girls may get acne.
Pubic Lice
What are pubic lice? Pubic lice (also called crabs) are tiny insects which usually live in the pubic or genital area of humans. They are also sometimes found on other coarse body hair, such as hair on the legs, armpits, mustache, beard, eyebrows, or eyelashes. Pubic lice on the eyebrows or eyelashes of children or teens may be a sign of sexual exposure or abuse . Pubic lice are parasites, and they need to feed on human blood to survive. They are one of the three types of lice that live on humans. The other two types are head lice and body lice . Each type of lice is different, and getting one type does not mean that you will get another type.